Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

ROSWELL PARK CANCER INSTITUTE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

Not Applicable

Recruiting

Conditions: Endometrial Carcinoma
Recurrent Fallopian Tube Carcinoma
Recurrent Ovarian Carcinoma
Recurrent Primary Peritoneal Carcinoma
Stage II Fallopian Tube Cancer AJCC v8
Stage II Ovarian Cancer AJCC v8
Stage II Primary Peritoneal Cancer AJCC v8
Stage III Fallopian Tube Cancer AJCC v8
Stage III Ovarian Cancer AJCC v8
Stage III Primary Peritoneal Cancer AJCC v8

First Posted Date: 2025-03-04

Last Posted Date: 2025-06-10

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 120

Registration Number: NCT06855706

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York

Not Applicable

Recruiting

Conditions: Breast Carcinoma

First Posted Date: 2025-02-18

Last Posted Date: 2025-06-13

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 125

Registration Number: NCT06833255

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

Phase 2

Not yet recruiting

Conditions: Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

Interventions: Procedure: Biospecimen Collection
Procedure: Functional Magnetic Resonance Imaging
Other: Interview
Drug: Psilocybine
Behavioral: Psychotherapy
Other: Questionnaire Administration

First Posted Date: 2025-02-14

Last Posted Date: 2025-05-14

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 20

Registration Number: NCT06827054

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Phase 2

Recruiting

Conditions: Borderline Resectable Pancreatic Ductal Adenocarcinoma

Interventions: Procedure: Biospecimen Collection
Procedure: Computed Tomography
Drug: Fluorouracil
Drug: Irinotecan Sucrosofate
Drug: Leucovorin Calcium
Drug: Oxaliplatin
Procedure: Surgical Procedure

First Posted Date: 2025-02-12

Last Posted Date: 2025-07-02

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 20

Registration Number: NCT06821997

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults

Early Phase 1

Recruiting

Conditions: Cigarette Smoking-Related Carcinoma

First Posted Date: 2025-02-10

Last Posted Date: 2025-06-22

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 30

Registration Number: NCT06816459

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation

Not Applicable

Recruiting

Conditions: Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

First Posted Date: 2025-01-29

Last Posted Date: 2025-05-20

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 28

Registration Number: NCT06798701

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting

Not Applicable

Recruiting

Conditions: Oncology
Extravasation

First Posted Date: 2025-01-03

Last Posted Date: 2025-06-08

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 2395

Registration Number: NCT06758011

Locations: 🇺🇸
Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States

A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

Phase 2

Recruiting

Conditions: Non-Muscle Invasive Bladder Carcinoma
Recurrent Bladder Carcinoma
Recurrent Non-Muscle Invasive Bladder Carcinoma
Stage 0a Bladder Cancer AJCC v8
Stage 1 Bladder Cancer AJCC v8

First Posted Date: 2024-12-13

Last Posted Date: 2025-06-08

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 344

Registration Number: NCT06733363

Locations: 🇺🇸
Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Phase 4

Recruiting

Conditions: Localized Prostate Carcinoma
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage III Prostate Cancer AJCC v8

Interventions: Procedure: Biopsy of Prostate
Procedure: Biospecimen Collection
Procedure: Magnetic Resonance Imaging
Other: Patient Observation
Other: Questionnaire Administration
Drug: Therapeutic Testosterone

First Posted Date: 2024-12-13

Last Posted Date: 2025-02-04

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 600

Registration Number: NCT06733350

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

A Community Health Education Intervention for Increasing Community-driven Actions to Reduce the Cancer Burden in Western New York

Not Applicable

Recruiting

Conditions: Healthy

First Posted Date: 2024-11-08

Last Posted Date: 2025-03-12

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 200

Registration Number: NCT06681077

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy